Unbound MEDLINE

Receptor for advanced glycation end products inhibits proliferation in osteoblast through suppression of Wnt, PI3K and ERK signaling.

Abstract

Expression of receptor for advanced glycation end products (RAGE) plays a crucial role in bone metabolism. However, the role of RAGE in the control of osteoblast proliferation is not yet evaluated. In the present study, we demonstrate that RAGE overexpression inhibits osteoblast proliferation in vitro. The negative regulation of RAGE on cell proliferation results from suppression of Wnt, PI3K and ERK signaling, and is restored by RAGE neutralizing antibody. Prevention of Wnt signaling using Sfrp1 or DKK1 rescues RAGE-decreased PI3K and ERK signaling and cell proliferation, indicating that the altered cell growth in RAGE overexpressing cells is in part secondary to alterations in Wnt signaling. Consistently, RAGE overexpression inhibits the expression of Wnt targets cyclin D1 and c-myc, which is partially reversed by RAGE blockade. Overall, these results suggest that RAGE inhibits osteoblast proliferation via suppression of Wnt, PI3K and ERK signaling, which provides novel mechanisms by which RAGE regulates osteoblast growth.

Links

  • Publisher Full Text
  • Authors

    Li G, Xu J, Li Z

    Institution

    Department of Emergency Surgery, East Hospital, Tongji University School of Medicine, Shanghai 200120, PR China.

    Source

    Biochemical and biophysical research communications 423:4 2012 Jul 13 pg 684-9

    MeSH

    Animals
    Cell Line
    Cell Proliferation
    Glycosylation End Products, Advanced
    MAP Kinase Signaling System
    Mice
    Osteoblasts
    Phosphatidylinositol 3-Kinases
    Receptors, Immunologic
    Signal Transduction
    Wnt Signaling Pathway
    beta Catenin

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    22699121